Posted On: 11/17/2014 5:20:56 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
I'm just guessing, but I think this acquisition is a way for them to receive non-dilutive financing to develop another asset. Back in 2010, the DoD gave Lonza $18M to develop this asset. Regenicin then licensed it from Lonza to develop for commercialization. If the DoD is still interested in this, perhaps there's more funding coming.
http://www.prnewswire.com/news-releases/depar...62559.html
http://www.prnewswire.com/news-releases/depar...62559.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)